What is the appropriate management for soreness on the undersurface of the knee?

Management of Soreness on the Underside of the Knee

Start with a structured exercise program targeting quadriceps and hip strengthening combined with patient education, as this represents the cornerstone of treatment for most causes of anterior/undersurface knee pain with the strongest evidence for improving pain and function.

Initial Assessment Priorities

When evaluating undersurface knee soreness, focus your clinical examination on:

• Age and activity level: If under 40 years and physically active, consider patellofemoral pain syndrome (91% sensitive with anterior pain during squatting) 1, 2
• Pain characteristics: Activity-related pain with less than 30 minutes of morning stiffness in patients over 45 years suggests knee osteoarthritis (95% sensitivity, 69% specificity) 2
• Functional limitations: Assess tolerance to loaded knee flexion, presence of quadriceps atrophy, and fear of movement during functional tasks 1
• Structural factors: Evaluate hip and knee strength, movement patterns during single-leg squat, tissue tolerance to load, and presence of effusion 1

Treatment Algorithm

First-Line: Non-Pharmacological Interventions (All Patients)

Exercise therapy is mandatory and should be prescribed immediately 3, 1:

• Knee-targeted strengthening: Quadriceps exercises if patient tolerates loaded knee flexion and demonstrates quadriceps atrophy
• Hip strengthening: Gluteal muscle strengthening, particularly if poor tolerance to loaded knee flexion exists 1, 4, 5
• Exercise parameters: Modify based on symptom severity and irritability; minimum 6-week trial before reassessment 1

Education and self-management 3:

• Explain that pain does not equal tissue damage
• Set realistic recovery timeframes
• Promote autonomy and reduce fear-avoidance behaviors
• Emphasize active over passive interventions 4

Weight reduction if overweight 3, 2: Large cohort studies demonstrate weight loss reduces knee OA risk

Second-Line: Adjunctive Interventions

For immediate pain relief to gain patient trust 4:

• Patellar taping: Use when rehabilitation is hindered by elevated symptom severity, irritability, or high fear of movement 1, 4
• Prefabricated foot orthoses: Prescribe when treatment direction tests show symptom improvement during functional tasks; customize for comfort 1, 2

Third-Line: Pharmacological Management

Paracetamol (acetaminophen) first 3:

• Initial oral analgesic of choice
• Preferred long-term analgesic if effective
• Doses up to 2600-4000 mg/day demonstrated safe for up to 2 years
• Comparable efficacy to ibuprofen in many patients

NSAIDs if paracetamol fails 3, 6:

• Topical NSAIDs: Safe first option (effect size 0.91 vs placebo) 6
• Oral NSAIDs: More efficacious than paracetamol but increased GI side effects
• In patients with GI risk: use COX-2 selective inhibitors or add gastroprotective agents 3

Intra-articular corticosteroid injection 3:

• Indicated for acute pain flares, especially with effusion
• Effective short-term (1-4 weeks) but not sustained at 12-24 weeks
• Effect size 1.27 for pain relief over 7 days

Fourth-Line: Advanced Interventions

If conservative measures fail after minimum 6 weeks 1:

• Extracorporeal shockwave therapy (ESWT): Most robust evidence for tibiofemoral osteoarthritis 7
• Platelet-rich plasma (PRP): Strong evidence for patellar tendinopathy long-term benefit; limited evidence for chondromalacia 7
• Botulinum toxin A: Strong evidence specifically for patellofemoral pain syndrome 7

Surgical Referral

Joint replacement consideration 3:

• Reserved for radiographic evidence of end-stage OA with refractory pain and disability
• Only after exhausting all appropriate conservative options
• 89% report good/excellent outcomes for pain and function up to 5 years 3

Critical Pitfalls to Avoid

1. Do not rush to imaging: Radiographic imaging is not recommended for all patients with possible knee OA 2
2. Do not prescribe passive treatments alone: Always emphasize active interventions (exercise) over passive modalities 4
3. Do not abandon treatment prematurely: Minimum 6-week trial required before concluding treatment failure 1
4. Do not ignore hip musculature: Hip abductor weakness and dynamic valgus are key contributors to anterior knee pain 5, 8

Evidence Strength Considerations

The EULAR guidelines 3 provide the most comprehensive framework, emphasizing that optimal management requires combining non-pharmacological and pharmacological modalities. The 2024 patellofemoral pain guideline 1 adds critical nuance about individualized assessment and multimodal exercise prescription. While older guidelines (2000-2003) form the evidence base, their core recommendations remain valid: exercise and education first, followed by stepwise pharmacological intervention.

The key divergence in evidence relates to NSAIDs versus paracetamol—while NSAIDs show superior efficacy, the safety profile of paracetamol makes it the preferred initial choice 3, 6. For patellofemoral pain specifically, the evidence strongly favors combined hip and knee strengthening over knee-only approaches 1, 4, 5.